INDIANAPOLIS, February 24 /PRNewswire/ --

PDS Biotechnology today announced that the company has obtained an exclusive license from Merck Eprova AG to utilize Merck Eprova's proprietary chiral lipid DOTAP Chloride in Versamune(TM)-HPV and other products in development based on the Versamune(TM) technology. The use of enantiomerically pure DOTAP Chloride shows enhanced adjuvant activity compared to the racemate. Merck Eprova AG will be providing enantiomerically pure DOTAP Chloride manufactured under cGMP for use in clinical and commercial drug products developed with PDS Biotechnology's Versamune(TM) nanoparticle technology. PDS Biotechnology will own the intellectual property rights to products incorporating the chiral DOTAP lipids for immunotherapeutic applications.

New evidence of a carnivorous killer has been found in Africa. This ancient killer almost had the misfortune of going extinct twice.

While evidence of 95-million year old therapods from Africa is quite scare making one think that each fragment would be treated like gold, this was not the case the first evidence of Carcharodontosaurus iguidensis, a newly described dinosaur from the Cenomanian of Nigeria and published in the December 2007 issue of the Journal of Vertebrate Paleontology.

CAMBRIDGE, Massachusetts, February 24 /PRNewswire/ --

Despite an overall economic contraction, network operator spending on telecom equipment in the Asia/Pacific region will rise slightly over the next 24 months, driven primarily by deployment of 3G networks in China, according to a new report from Pyramid Research (http://www.pyr.com), the telecom research arm of the Light Reading Communications Network (http://www.lightreading.com ).

GENEVA, February 24 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and Ambrx Inc, today announced a global strategic collaboration to develop and commercialize Ambrx's ARX424 preclinical product candidate for the treatment of multiple sclerosis. ARX424 was created by Ambrx through the application of its proprietary protein optimization technology, ReCODE(TM).

This second collaboration between the two companies follows a previous agreement announced in 2007 to develop ARX201, Ambrx's long-acting growth hormone product, currently in Phase II of clinical development.

PALO ALTO, California, February 24 /PRNewswire/ --

- Funding to advance novel Hepatitis C Virus (HCV) therapies against new targets

Eiger BioPharmaceuticals, Inc., a start-up biotechnology company developing antiviral therapies, announced that it has raised US$7.1 million in a Series A financing co-led by InterWest Partners and Vivo Ventures. The two firms were instrumental in the formation of the company and recruitment of its team and are represented on the board of directors by general partners Nina Kjellson and Dr. Edgar Engelman, respectively. The funding will advance the company's lead program targeted against NS4B, a specific region in the hepatitis C virus (HCV) protein, as well as progress lead identification for other proprietary targets.

SANTA CLARA, California, February 24 /PRNewswire/ --

- Multiple companies adopt SheevaPlug(TM) development platform to showcase new network-based applications that are designed to be simple to install and easy to use

Marvell (Nasdaq: MRVL) today announced its Plug Computing initiative to make high-performance, always on, always connected, and environmentally friendly computing readily available for developers and end-users. A Plug Computer is small enough to plug directly into a wall socket and is designed to draw so little power that it can be left on all of the time. Unlike other embedded devices in the home, it contains a gigahertz class processor to offer PC class performance. This makes it a viable alternative to a PC for any software service.

DENVER, February 24 /PRNewswire/ --

Altira Group LLC - a pioneer and leader in venture capital and private equity funding for energy technology companies, today announced it will be hosting a thought-leadership panel, Debunking Dirty Technology Myths: From Campaign Rhetoric to Action at CleanTech XXI in San Francisco on Tuesday February 24, 2009 at 3:30pm PST.

This interactive session will examine the controversial topics of nuclear energy, clean coal, and hydrocarbons, contesting current popular myths based on decades-old information. The panel will demonstrate why these energy sources are required to meet growing energy demand today, and how technology gains and efficiencies have dramatically advanced their benefits.

BRISTOL, England, February 24 /PRNewswire/ -- Computershare Governance Services (CGS), part of the Computershare group of companies (ASX:CPU) has won a prestigious contract to supply Norwegian company StatoilHydro with its Global Entity Management System (GEMS).

Created in 2007 from the merger of Statoil and Hydro's oil and gas activities, the company has approximately 29,500 employees in 40 countries, and is the operator for 39 producing oil and gas fields.

CGS won the contract following a rigorous procurement process, including requiring providers to achieve accreditation to Achilles Joint Qualification System, the database used by Norwegian and Danish gas and oil operators when selecting suppliers.

NEW YORK, February 24 /PRNewswire/ -- Babylon LTD (TASE: BBYL), a world leading provider of online and offline dictionary and translation solutions, has ranked No. 1 in the review of the 2009 translation software carried out by TopTen Reviews and ranked above the competition and took the TopTenREVIEWS Gold Award http://translation-software-review.toptenreviews.com/babylon-6-review.html .